HUP0103071A3 - Pharmaceutical composition containing citalopram - Google Patents

Pharmaceutical composition containing citalopram

Info

Publication number
HUP0103071A3
HUP0103071A3 HU0103071A HUP0103071A HUP0103071A3 HU P0103071 A3 HUP0103071 A3 HU P0103071A3 HU 0103071 A HU0103071 A HU 0103071A HU P0103071 A HUP0103071 A HU P0103071A HU P0103071 A3 HUP0103071 A3 HU P0103071A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
composition containing
containing citalopram
citalopram
pharmaceutical
Prior art date
Application number
HU0103071A
Other languages
Hungarian (hu)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0103071(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HU0103071D0 publication Critical patent/HU0103071D0/en
Publication of HUP0103071A2 publication Critical patent/HUP0103071A2/en
Publication of HUP0103071A3 publication Critical patent/HUP0103071A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
HU0103071A 2000-08-10 2001-07-26 Pharmaceutical composition containing citalopram HUP0103071A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (3)

Publication Number Publication Date
HU0103071D0 HU0103071D0 (en) 2001-10-28
HUP0103071A2 HUP0103071A2 (en) 2002-05-29
HUP0103071A3 true HUP0103071A3 (en) 2002-12-28

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103071A HUP0103071A3 (en) 2000-08-10 2001-07-26 Pharmaceutical composition containing citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (en)
JP (1) JP2003531153A (en)
KR (1) KR20030024833A (en)
CN (1) CN1446089A (en)
AR (1) AR030095A1 (en)
AT (1) AT5744U1 (en)
AU (2) AU2001100198B4 (en)
BE (1) BE1013559A6 (en)
BG (1) BG107578A (en)
BR (1) BR0113250A (en)
CA (1) CA2353693C (en)
CH (2) CH694241A5 (en)
CZ (1) CZ2003397A3 (en)
DE (2) DE20113195U1 (en)
EA (1) EA200300247A1 (en)
ES (1) ES2172481B2 (en)
FI (1) FI5176U1 (en)
FR (1) FR2812811B1 (en)
GB (1) GB2368014B (en)
GR (1) GR1004193B (en)
HR (1) HRP20030054A2 (en)
HU (1) HUP0103071A3 (en)
IE (1) IES20010693A2 (en)
IL (1) IL154050A0 (en)
IS (1) IS6021A (en)
IT (1) ITMI20011637A1 (en)
MX (1) MXPA03000837A (en)
NL (1) NL1018741C1 (en)
NO (1) NO20013891L (en)
NZ (1) NZ523785A (en)
PL (1) PL359824A1 (en)
SK (1) SK2842003A3 (en)
WO (1) WO2001080619A2 (en)
YU (1) YU9003A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ATE388947T1 (en) * 2002-12-23 2008-03-15 Lundbeck & Co As H ESCITALOPRAM HYDROBROMIDE AND A METHOD FOR THE PRODUCTION THEREOF
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (en) * 2006-01-05 2007-12-12 昆明积大制药有限公司 Antidepressant composition containing citalopram and cyclodextrin
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
WO2017020841A1 (en) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 Pharmaceutical composition containing lcz696 and preparation method thereof
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug response by a serotonin 1A receptor antagonist
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
NO20013891L (en) 2002-02-11
YU9003A (en) 2006-05-25
IES20010693A2 (en) 2002-07-10
NO20013891D0 (en) 2001-08-09
AT5744U1 (en) 2002-11-25
CZ2003397A3 (en) 2003-06-18
JP2003531153A (en) 2003-10-21
CA2353693C (en) 2003-07-22
FR2812811B1 (en) 2006-08-18
BG107578A (en) 2003-09-30
ES2172481B2 (en) 2004-08-01
CH694241A5 (en) 2004-10-15
NZ523785A (en) 2004-09-24
HU0103071D0 (en) 2001-10-28
IL154050A0 (en) 2003-07-31
AU2001279591A1 (en) 2001-11-07
DE10139115A1 (en) 2002-03-28
GB2368014A (en) 2002-04-24
ITMI20011637A0 (en) 2001-07-27
SK2842003A3 (en) 2003-09-11
WO2001080619A2 (en) 2001-11-01
AR030095A1 (en) 2003-08-13
CN1446089A (en) 2003-10-01
GR20010100377A (en) 2002-09-06
AU2001100198B4 (en) 2002-06-13
ITMI20011637A1 (en) 2003-01-27
CA2353693A1 (en) 2002-01-22
WO2001080619A3 (en) 2002-02-21
IS6021A (en) 2001-10-20
FR2812811A1 (en) 2002-02-15
BR0113250A (en) 2003-06-24
ES2172481A1 (en) 2002-09-16
FI5176U1 (en) 2001-12-27
BE1013559A6 (en) 2002-03-05
EA200300247A1 (en) 2003-06-26
HRP20030054A2 (en) 2005-02-28
GR1004193B (en) 2003-03-24
GB2368014B (en) 2004-06-23
HUP0103071A2 (en) 2002-05-29
GB0118579D0 (en) 2001-09-19
KR20030024833A (en) 2003-03-26
EP1318805A2 (en) 2003-06-18
AU2001100198A4 (en) 2001-08-16
MXPA03000837A (en) 2003-06-06
NL1018741C1 (en) 2002-02-12
CH694242A5 (en) 2004-10-15
DE20113195U1 (en) 2001-11-15
PL359824A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
HUP0204555A3 (en) Pharmaceutical composition
GB0001621D0 (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HK1057474A1 (en) Medicinal composition
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB2368014B (en) Pharmaceutical composition containing citalopram
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
HRP20030546A2 (en) Pharmaceutical composition containing citalopram
GB0005382D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0219820D0 (en) Pharmaceutical compostion containing citalopram
DK200100203U4 (en) Pharmaceutical composition containing citalopram
HU0000060D0 (en) Novel pharmaceutical compositions
GB0008872D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished